The DOI matches its Crossref record; 487 of the 487 references it cites were found in a registry or an index.
Changes in Proinflammatory Cytokine Activity after Menopause
Abstract
There is now a large body of evidence suggesting that the decline in ovarian function with menopause is associated with spontaneous increases in proinflammatory cytokines. The cytokines that have obtained the most attention are IL-1, IL-6, and TNF-α. The exact mechanisms by which estrogen interferes with cytokine activity are still incompletely known but may potentially include interactions of the ER with other transcription factors, modulation of nitric oxide activity, antioxidative effects, plasma membrane actions, and changes in immune cell function. Experimental and clinical studies strongly support a link between the increased state of proinflammatory cytokine activity and postmenopausal bone loss. Preliminary evidence suggests that these changes also might be relevant to vascular homeostasis and the development of atherosclerosis. Better knowledge of the mechanisms and the time course of these interactions may open new avenues for the prevention and treatment of some of the most prevalent and important disorders in postmenopausal women.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Changes in energy balance and body composition at menopause: a controlled longitudinal study.
Poehlman, E. T., Toth, M. J., & Gardner, A. W. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-9-199511010-00005 · Cited by 520
RetractedAtherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Acute-Phase Proteins and Other Systemic Responses to Inflammation
Gabay, C., & Kushner, I. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400607 · Cited by 6,734
Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439
NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune Responses
Ghosh, S., May, M. J., & Kopp, E. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.225 · Cited by 5,182
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.
Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130
Biologic basis for interleukin-1 in disease.
Dinarello, C. (1996) · Blood · doi:10.1182/blood.v87.6.2095.bloodjournal8762095 · Cited by 4,344
Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3597 · Cited by 4,228
NF-κB: a key role in inflammatory diseases
Tak, P. P., & Firestein, G. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11830 · Cited by 3,918
Research works printed but not linked: 31
- Vargas, 1996, Lack of evidence for an increase in interleukin-6 expression in adult murine bone, bone marrow, and marrow stromal cell cultures after ovariectomy., J Bone Miner Res, 11, 1926, 10.1002/jbmr.5650111214 · doi:10.1002/jbmr.5650111214
- Girasole, 1995, Increased serum-soluble interleukin-6 receptor levels are induced by ovariectomy, prevented by estrogen replacement and reversed by alendronate administration, J Bone Miner Res, 10, A86
- Martinetti, 2000, The luteinising hormone-releasing hormone analogue triptorelin with or without the aromatase inhibitor formestane in premenopausal breast cancer: effects on bone metabolism markers., J Steroid Biochem Mol Biol, 75, 65, 10.1016/S0960-0760(00)00138-2 · doi:10.1016/s0960-0760(00)00138-2
- O’Brien, 1999, In vivo demonstration of the negative transcriptional control of the IL-6 gene by estrogen using IL-6 promoter-luciferase transgenic mice, J Bone Miner Res, 14, S179
- Wang, 1999, The expression of transforming growth factor-β and interleukin-1β mRNA and the response to 1,25(OH)2D3′ 17β-estradiol, and testosterone is age-dependent in primary cultures of mouse-derived osteoblasts in vitro., Endocrine, 11, 13, 10.1385/ENDO:11:1:13 · doi:10.1385/endo:11:1:13
- Scheidt-Nave, 1999, Serum interleukin-6 is a major predictor of bone loss in women specific to the first decade past menopause, J Bone Miner Res, 14, S147
- Sunyer, 1997, Estrogen decreases the steady state levels of the IL-1 signaling receptor (type I) while increasing those of the IL-1 decoy receptor (type II) in human osteoclast-like cells, J Bone Miner Res, 12, 131
- Woodfork, 2001, Cytokine and nitric oxide release by J774A.1 macrophages is not regulated by estradiol., Life Sci, 69, 2287, 10.1016/S0024-3205(01)01304-2 · doi:10.1016/s0024-3205(01)01304-2
- Paul, 1998, Effects of raloxifene and hormone replacement therapy on homocysteine and c-reactive protein levels in postmenopausal women, Circulation, 17, I7
- Sachs, 1994, The network of hematopoietic cytokines., Proc Soc Exp Biol Med, 206, 170, 10.3181/00379727-206-43736 · doi:10.3181/00379727-206-43736
- Simoncini, 2000, Raloxifene acutely stimulates nitric oxide release from human endothelial cells via an activation of endothelial nitric oxide synthase., J Clin Endocrinol Metab, 85, 2966, 10.1210/jcem.85.8.6853 · doi:10.1210/jcem.85.8.6853
- Konukoglu, 2000, Effects of hormone replacement therapy on plasma nitric oxide and total thiol levels in postmenopausal women., J Toxicol Environ Health, 60, 81, 10.1080/009841000156501 · doi:10.1080/009841000156501
- Jouzeau, 1999, Modulation of IL-1 effects on cartilage by NO synthase inhibitors: pharmacological studies in rats., Osteoarthritis Cartilage, 7, 382, 10.1053/joca.1998.0218 · doi:10.1053/joca.1998.0218
- Subbiah, 1998, Mechanisms of cardioprotection by estrogens., Proc Soc Exp Biol Med, 217, 23, 10.3181/00379727-217-44201 · doi:10.3181/00379727-217-44201
- Melton, 2000, Sex is all in the brain: report of a Novartis Foundation Symposium on the neuronal and cognitive effects of oestrogens, London UK, 7–9 September 1999., Trends Endocrinol Metab, 11, 69, 10.1016/S1043-2760(99)00231-3 · doi:10.1016/s1043-2760(99)00231-3
- Gurdol, 1997, Changes in enzymatic antioxidant defense system in blood and endometrial tissues of women after menopause., Res Comm Mol Pathol Pharmacol, 97, 38
- Seo, 1995, Immature B-lymphopoiesis accumulating in estrogen deficiency stimulate IL-6 production by mouse bone marrow stromal cells, J Bone Miner Res, 10, S159
- Akgul, 1998, Hormone replacement therapy and urinary prostaglandins in postmenopausal women., Maturitas, 30, 79, 10.1016/S0378-5122(98)00046-2 · doi:10.1016/s0378-5122(98)00046-2
- Pacifici, 1995, Cytokines and osteoclast activity, Calcif Tissue Int, 56, S27, 10.1007/BF03354648 · doi:10.1007/bf03354648
- Marusic, 1991, Effects of transforming growth factor-β and IL-1 α on prostaglandin synthesis in serum-deprived osteoblastic cells., J Immunol, 146, 2633, 10.4049/jimmunol.146.8.2633 · doi:10.4049/jimmunol.146.8.2633
- Harrison, 1990, Interleukin-1 α and phorbol ester inhibit collagen synthesis in osteoblastic MC3T3-E1 cells by a transcriptional mechanism., Mol Endocrinol, 4, 184, 10.1210/mend-4-2-184 · doi:10.1210/mend-4-2-184
- Bradbeer, 1996, An orally active inhibitor of cytokine synthesis prevents bone loss in the ovariectomized rat, J Bone Miner Res, 11, 123
- Slater, 1994, Modulation of growth factor incorporation into ECM of human osteoblast-like cells in vitro by 17 β estradiol, Am J Physiol, 267, E990
- Erdmann, 1998, Effects of estrogen on the concentration of insulin-like growth factor-I in rat bone matrix., Bone, 22, 503, 10.1016/S8756-3282(98)00043-X · doi:10.1016/s8756-3282(98)00043-x
- Elhage, 2000, Loss of atheroprotective effect of estradiol in immunodeficient mice., Endocrinology, 141, 462, 10.1210/endo.141.1.7377 · doi:10.1210/endo.141.1.7377
- Masiukiewicz, 2000, Estrogen modulates parathyroid hormone-induced interleukin-6 production in vivo and in vitro., Endocrinology, 141, 2526, 10.1210/endo.141.7.7537 · doi:10.1210/endo.141.7.7537
- Tsukamoto, 1999, Association of radial bone mineral density with CA repeat polymorphism at the interleukin 6 locus in postmenopausal Japanese women., J Hum Genet, 44, 148, 10.1007/s100380050132 · DOI
- Langdahl, 1999, An 86 basepair repeat in the interleukin 1 receptor antagonist gene is weakly associated with peak bone mass, but not with early postmenopausal bone loss or the response to HRT, J Bone Miner Res, 14, S334
- Ferrari, 2001, A functional polymorphic variant in the interleukin-6 gene promoter associated with low bone resorption in postmenopausal women., Arthritis Rheum, 44, 196, 10.1002/1529-0131(200101)44:1<196::AID-ANR26>3.0.CO;2-5 · doi:10.1002/1529-0131(200101)44:1<196::aid-anr26>3.0.co;2-5
- Kluft, 1999, Statins and C-reactive protein., Lancet, 353, 1274, 10.1016/S0140-6736(05)66951-6 · doi:10.1016/s0140-6736(05)66951-6
- Mbalaviele, 1999, Blockade of cytokine-mediated human osteoclastogenesis by activation of peroxisome proliferator-activated receptor-γ pathway, J Bone Miner Res, 14, S358
Cited by
The complex role of estrogens in inflammation
Straub, R. H. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0001 · Cited by 1,950
Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!)
Berenbaum, F. (2013) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2012.11.012 · Cited by 1,718
The Emergence of the Metabolic Syndrome with Menopause
Carr, M. C. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030242 · Cited by 1,449
The role of estrogens in control of energy balance and glucose homeostasis
Mauvais-Jarvis, F., Clegg, D. J., & Hevener, A. L. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1055 · Cited by 1,329
Estrogen deficiency and bone loss: an inflammatory tale
Weitzmann, M. N. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28550 · Cited by 990
Metadata
- Authors
- Pfeilschifter, J., Köditz, R., Pfohl, M., & Schatz, H.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2002-02-01
- Volume
- 23
- Issue
- 1
- Pages
- 90-119
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2060551064
- Cited by
- 914
- References
- 487
- FWCI
- 16.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Changes in Proinflammatory Cytokine Activity after Menopause. https://app.cochat.ai/papers/10.1210/edrv.23.1.0456
- The paper
- Pfeilschifter, J., Köditz, R., Pfohl, M., & Schatz, H. (2002). Changes in Proinflammatory Cytokine Activity after Menopause. Endocrine Reviews. https://doi.org/10.1210/edrv.23.1.0456
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.